Clearside Biomedical Inc (CLSD)

08:27 AM

What drives Clearside Biomedical Inc. stock priceFree Real-Time Stock Data - PrintWeekIndia

08:27 AM

03:34 AM

What analysts say about Clearside Biomedical Inc. stockBreakthrough stock performance - PrintWeekIndia

03:34 AM

Jul 24, 2025

Why Clearside Biomedical Inc. stock attracts strong analyst attentionFree Stock Market Analysis Courses - Newser

Jul 24, 2025

Jul 24, 2025

Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery - MSN

Jul 24, 2025

Jul 24, 2025

Clearside Biomedical Announces Approval of XIPERE® - GlobeNewswire

Jul 24, 2025

Jul 23, 2025

Is Clearside Biomedical Inc. a good long term investmentExceptional portfolio growth - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Clearside Biomedical stock soars after Health Canada approves XIPERE - Investing.com Australia

Jul 23, 2025

Jul 23, 2025

Clearside Biomedical stock soars after Health Canada approves XIPERE By Investing.com - Investing.com UK

Jul 23, 2025

Jul 23, 2025

Health Canada approves Clearside’s XIPERE for uveitic macular edema By Investing.com - Investing.com Nigeria

Jul 23, 2025

Jul 23, 2025

Breakthrough Eye Treatment XIPERE Secures Major Health Canada Approval for Macular Edema - Stock Titan

Jul 23, 2025

Jul 22, 2025

Clearside Biomedical Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Clearside exploring options to advance suprachoroidal delivery platform - Eyes On Eyecare

Jul 22, 2025

Jul 22, 2025

Clearside Biomedical announces plan to explore strategic alternatives to advance its proprietary suprachoroidal space (SCS) delivery platform and promising ophthalmology pipeline - Eyes On Eyecare

Jul 22, 2025

Jul 21, 2025

Analysts Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Target Price at $4.20 - Defense World

Jul 21, 2025

Jul 21, 2025

Uncovering the Potential of Clearside Biomedical Inc (CLSD) Stock - investchronicle.com

Jul 21, 2025

Jul 21, 2025

Clearside Biomedical (NASDAQ:CLSD) Downgraded by Stifel Nicolaus to "Hold" - MarketBeat

Jul 21, 2025

Jul 20, 2025

Chardan Capital Downgrades Clearside Biomedical (NASDAQ:CLSD) to Neutral - Defense World

Jul 20, 2025

Jul 19, 2025

What institutions are buying Clearside Biomedical Inc. stock nowFree Stock Trading Signals - beatles.ru

Jul 19, 2025

Jul 18, 2025

Published on: 2025-07-18 21:44:13 - Newser

Jul 18, 2025

Jul 18, 2025

Clearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright - TipRanks

Jul 18, 2025

Jul 18, 2025

Health Care Stocks Stumble As Sector Faces Fresh Setbacks - Finimize

Jul 18, 2025

Jul 18, 2025

Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie - Benzinga

Jul 18, 2025

Jul 18, 2025

Published on: 2025-07-18 22:42:56 - jammulinksnews.com

Jul 18, 2025

Jul 18, 2025

This Verint Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Jul 18, 2025

Jul 18, 2025

A Quick Look at Today's Ratings for Clearside Biomedical(CLSD.US), With a Forecast Between $0.84 to $3 - 富途牛牛

Jul 18, 2025

Jul 18, 2025

Clearside Biomedical downgraded to Neutral from Buy at Chardan - TipRanks

Jul 18, 2025

Jul 18, 2025

This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

Jul 18, 2025

Jul 18, 2025

CLSD: Downgraded to Neutral by HC Wainwright & Co. | CLSD Stock News - GuruFocus

Jul 18, 2025

Jul 18, 2025

Why Clearside Biomedical Inc. stock is on top investor watchlistsHigh Return Stock Alerts - Newser

Jul 18, 2025

Jul 18, 2025

Chardan Capital downgrades Clearside Biomedical stock rating to Neutral By Investing.com - Investing.com Canada

Jul 18, 2025

Jul 18, 2025

Chardan Capital downgrades Clearside Biomedical stock rating to Neutral - Investing.com

Jul 18, 2025

Jul 18, 2025

Stifel downgrades Clearside Biomedical stock to Hold on cash concerns By Investing.com - Investing.com Nigeria

Jul 18, 2025

Jul 18, 2025

Stifel downgrades Clearside Biomedical stock to Hold on cash concerns - Investing.com Australia

Jul 18, 2025

Jul 17, 2025

Clearside Biomedical Downgraded to Hold Amid Strategic and Financial Uncertainties - TipRanks

Jul 17, 2025

Jul 17, 2025

Clearside Biomedical downgraded to Hold from Buy at Stifel - TipRanks

Jul 17, 2025

Jul 17, 2025

Clearside Biomedical Announces Plan to Explore Strategic - GlobeNewswire

Jul 17, 2025